Stocks to invest in – 13D Filing: Care Capital and Minerva Neurosciences, Inc. (NERV)

Stocks to invest in

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Care Capital Investments III 0 1,534,098 0 1,534,098 1,534,098 5.5%
Care Capital Offshore Investments III 0 25,618 0 25,618 25,618 0.1%
Care Capital III 0 1,559,716 0 1,559,716 1,559,716 5.6%

Page 1 of 7 – SEC Filing









Washington, D.C. 20549









Under the Securities Exchange Act of 1934
(Amendment No. 4)(1)



(Name of Issuer)


Common Stock, $0.0001 par value per share

(Title of Class of Securities)


(CUSIP Number)


David R. Ramsay

Care Capital III LLC

47 Hulfish Street, Suite 310

Princeton, New Jersey 08542


(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)


(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o


Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See §240.13d-7 for other parties to whom copies are to be sent.


(1) The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.


The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


Follow Minerva Neurosciences, Inc. (NASDAQ:NERV)

Trade (NASDAQ:NERV) Now!

Biotech Insider Alert – $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund’s #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it’s sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

– Stocks to invest in

Learn How To Be #1 on Google Results

Source link